The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain

Human Psychopharmacology

Volumn 18, Issue 7, 2003, Pages 551-557

  Fitzgerald, Paul B ^a   Scaffidi, Antonietta ^a   Morris, Margaret J ^b   de Castella, Anthony R ^a   Kulkarni, Jayashri ^a  

^a Department of Psychological Medicine ^*  (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antipsychotic medication; Leptin; Neuropeptide Y; Oestrogen; Schizophrenia; Weight gain

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; ESTRADIOL; ESTROGEN; FOLLITROPIN; LEPTIN; LUTEINIZING HORMONE; NEUROPEPTIDE Y; OLANZAPINE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; RISPERIDONE; SEROTONIN; SEROTONIN RECEPTOR; SEX HORMONE; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; PRIORITY JOURNAL; RECEPTOR BLOCKING; SCHIZOPHRENIA; TIME; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; GONADAL STEROID HORMONES; HUMANS; LEPTIN; MIDDLE AGED; NEUROPEPTIDE Y; PIRENZEPINE; RADIOIMMUNOASSAY; RISPERIDONE; SCHIZOPHRENIA; TIME FACTORS; WEIGHT GAIN;

EID: 0142042882     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.519     Document Type: Article

References (44)

1. Ainslie D, Morris MJ, Wittert G, et al. 2001. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obs Relat Metab Disord 25: 1680-1688.
2. Allison DB, Mentore JL, Heo M, et al. 1999. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686-1696.
3. Aso T, Matsuoka M, Su J, et al. 1982. Influence of sulpiride-induced hyperprolactinemia on baboon menstrual cycles: a longitudinal study. J Med Primatol 11: 20-34.
4. Baptista T. 1999. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 100: 3-16.
5. Baptista T, Alastre T, Contreras Q, et al. 1997. Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation. Pharmacopsychiatry 30: 250-255.
6. Baptista T, Reyes D, Hernandez L. 1999. Antipsychotic drugs and reproductive hormones: relationship to body weight regulation. Pharmacol Biochem Behav 62: 409-417.
7. Barnes TR. 1989. A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672-676.
8. Cabrera R, Mayor P, Fernandez-Ruiz J, Calle C. 1988. Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia. Mol Cell Endocrinol 58: 167-173.
9. Carter DA, McGarrick GM, Norton KR, et al. 1982. The effect of chronic neuroleptic treatment on gonadotrophin release. Psychoneuroendocrinology 7: 201-207.
10. Chehab FF. 1997. The reproductive side of leptin. Nat Med 3: 952-953.
11. Chehab FF, Mounzih K, Lu R, Lim ME. 1997. Early onset of reproductive function in normal female mice treated with leptin. Science 275: 88-90.
12. Chu SC, Chou YC, Liu JY, et al. 1999. Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement. Life Sci 64: 2299-2306.
13. Correa N, Opler LA, Kay SR, Birmaher B. 1987. Amantadine in the treatment of neuroendocrine side effects of neuroleptics. J Clin Psychopharmacol 7: 91-95.
14. Crandall DL, Busler DE, Novak TJ, et al. 1998. Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. Biochem Biophys Res Commun 248: 523-526.
15. Ebeling P, Koivisto VA. 1994. Physiological importance of dehydroepiandrosterone. Lancet 343: 1479-1481.
16. Genazzani AR, Bernardi F, Monteleone P, et al. 2000. Neuropeptides, neurotransmitters, neurosteroids, and the onset of puberty. Ann N Y Acad Sci 900: 1-9.
17. Halford JC, Blundell JE. 2000. Separate systems for serotonin and leptin in appetite control. Ann Med 3: 222-232.
18. Hastings JA, Wiesner G, Lambert G, et al. 2002. Influence of leptin on neurotransmitter overflow from the rat brain in vitro. Regul Pept 103: 67-74.
19. Herran A, Garcia-Unzueta MT, Amado JA, et al. 2001. Effects of long-term treatment with antipsychotics on serum leptin levels. Br J Psychiatry 179: 59-62.
20. Jockenhovel F, Blum WF, Vogel E, et al. 1997. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab 82: 2510-2513.
21. Johnson RD. 1995. Opioid involvement in feeding behaviour and the pathogenesis of certain eating disorders. Med Hypotheses 45: 491-497.
22. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276.
23. Kraus T, Haack M, Schuld A, et al. 1999. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156: 312-314.
24. Kraus T, Haack M, Schuld A, et al. 2001. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 73: 243-247.
25. Kulkarni J, de Castella A, Thompson C. 1997. Assessment of the menstrual cycle phase in women with schizophrenia. Schizophr Res 26: A81-A82.
26. Longcope C, Baker R, Johnston CC, Jr. 1986. Androgen and estrogen metabolism: relationship to obesity. Metabolism 35: 235-237.
27. Mantzoros CS. 1999. Leptin and the hypothalamus: neuroendocrine regulation of food intake. Mol Psychiatry 4: 8-12.
28. Melkersson KI, Hulting AL. 2001. Insulin and leptin levels in patients with schizophrenia or related psychoses - a comparison between different antipsychotic agents. Psychopharmacology (Berl) 154: 205-212.
29. Melkersson KI, Hulting AL, Brismar KE. 2000. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 61: 742-749.
30. Montogomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
31. Morris MJ, Cox HS, Lambert GW, et al. 1997. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension 29: 137-143.
32. Morris MJ, Russell AE, Kapoor V, et al. 1986. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J Auton Nerv Syst 17: 143-149.
33. Munetz MR, Benjamin S. 1988. How to examine patients using the Abnormal Involuntary Movement Scale. Hosp Community Psychiatry 39: 1172-1177.
34. Munglani R, Hudspith MJ, Hunt SP. 1996. The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive. Drugs 52: 371-389.
35. Okonmah AD, Bradshaw WG, Couceyro P, Soliman KF. 1986. The effect of neuroleptic drugs on serum testosterone level in the male rat. Gen Pharmacol 17: 235-238.
36. Peters J, Van Kammen DP, Gelernter J, et al. 1990. Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures. Schizophr Res 3: 287-294.
37. Rohner-Jeanrenaud F, Jeanrenaud B. 1996. Obesity, leptin, and the brain. N Engl J Med 334: 324-325.
38. Simpson GM, Angus JWS. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212(Suppl. 44): 11-19.
39. Spark RF, Wills CA, O'Reilly G, et al. 1982. Hyperprolactinaemia in males with and without pituitary macroadenomas. Lancet 2: 129-132.
40. Spitzer RL, Williams JB, Gibbon M, First MB. 1992. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 49: 624-629.
41. Vettor R, De Pergola G, Pagano C, et al. 1997. Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest 27: 1016-1024.
42. Wade GN, Schneider JE. 1992. Metabolic fuels and reproduction in female mammals. Neurosci Biobehav Rev 16: 235-272.
43. Xu X, De Pergola G, Bjorntorp P. 1990. The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 126: 1229-1234.
44. Yu WH, Kimura M, Walczewska A, et al. 1997. Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci USA 94: 1023-1028.